logo transparent gif
top_left_edge top_white_spacer top_right_edge
Home Latest Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Return

TJ DaRenTang USD

T14

2.2

No Change

GroupCash
CashUS Dollar

 

TRADING INFO


Open
-
Buy
-
Sell
-
High
-
Low
-
Previous Close
2.2
Volume(K)
0.0
Buy Volume(K)
-
Sell Volume(K)
-

KEY STOCK INFOUpdated: 04 Jul 2024


PE Ratio (FY)
3.4345531145517363
Dividend Yield % (FY)
29.089194078924073
Price to Book Ratio
0.5424063116370809
Market Cap ($million)
3388.8976000000002
Enterprise Value ($million)
1543.0146000000002
52 Weeks High
2.66
52 Weeks Low
1.66
RSI
32.7 ( No Info )
Williams %R
-97.62 ( Oversold )

 

COMPANY INFORMATION Updated: 29 Jun 2024 Financial Info by


SIC
MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Address
NO.17 BAIDI ROAD NANKAI DISTRICT TIANJIN 300193
Phone
(86) 022 2702 0926
Fax
(86) 022 2702 0892
Profile
The Company is mainly engaged in the Chinese herbal medicine, Chinese medicine, Chinese herbal medicine, western medicine, chemical medicine manufacturing, chemical medicine, medical, nutrition and health care products, chemical processing, manufacturing, wholesale and retail; traditional Chinese medicine processing, health supplies, fitness equipment, life and environmental health disinfection supplies, drugs, daily necessities, clothing and skin care products, footwear, household appliances, daily necessities, tobacco wholesale and retail; warehousing, advertising, technology development and transfer, economic information consulting services, such as rental housing.

 

FINANICALS INFORMATION All values in $millions


Financial Year
2020-12-31
2021-12-31
2022-12-31
Currency
CNY
CNY
CNY
KEY RATIOS
FY 2020
FY 2021
FY 2022

Operating Margin(%)
11.759
12.826
12.146
Return on Equity Capital(%)
11.535
12.342
13.192
Net Profit Margin(%)
10.131
11.264
10.568
Current Ratio
2.59
2.64
2.174
Debt to Capital at Book
0.033
0.075
0.093
INCOME STATEMENT
FY 2020
FY 2021
FY 2022

EBITDA
664.257
717.14
859.06
EBIT
580.929
613.689
666.195
Net Profit
661.705
769.145
861.794
Ordinary Dividend
-232.093
-386.722
-866.256
BALANCE SHEET
FY 2020
FY 2021
FY 2022

Intangibles
204.023
202.908
376.823
Fixed Assets
1457.053
1483.273
1461.592
Long Term Investments
803.849
740.741
801.465
Stock/Inventories
1487.715
1525.089
1429.453
Cash
1987.334
2283.181
2711.533
Current Liabilities
2163.851
2433.902
3333.435
Long Term Debt
33.949
3.949
155.249
Provisions
30.66
12.445
10.091
Minorities
0.0
0.0
0.0
Total Shareholder Equity
5949.894
6513.829
6551.953
PER SHARE INFO
FY 2020
FY 2021
FY 2022

EBITDA per share
0.429
0.464
0.555
EBIT per share
0.496
0.564
0.634
Profit Per Share
0.428
0.497
0.557
Book Value Per Share
3.714
4.079
3.992

 

 


Intraday Chart




ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux.